Jordan vs Solomon Islands: The number of people with susceptibility test result for rifampicin
Jordan
62
in 2021
Solomon Islands
66
in 2021
Jordan rank
117th
Solomon Islands rank
115th
The number of people with susceptibility test result for rifampicin over time
- Jordan
- Solomon Islands
How they compare
Solomon Islands currently reports 66 against 62 in Jordan, a difference of 4.
That makes Solomon Islands's figure about 1.1 times Jordan's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Jordan ahead.
Jordan ranks 117th and Solomon Islands ranks 115th of 155 countries.
Jordan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Jordan | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 84.33 | 0 | 84.33 | Jordan |
| 2020s | 86 | 86 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Jordan or Solomon Islands?
- Solomon Islands, at 66 against 62 in Jordan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Jordan and Solomon Islands?
- 4, with Solomon Islands ahead.
- How many years of comparable data are there for Jordan and Solomon Islands?
- 5 years are reported by both, from 2017 to 2021.
- How do Jordan and Solomon Islands rank globally for the number of people with susceptibility test result for rifampicin?
- Jordan ranks 117th and Solomon Islands ranks 115th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.